XML 21 R9.htm IDEA: XBRL DOCUMENT
v3.24.3

Note 3 - Cash, Cash Equivalents, and Marketable Securities | 9 Months Ended
--- | ---
Sep. 30, 2024
Notes to Financial Statements |
Cash, Cash Equivalents, and Marketable Securities [Text Block] | Note 3. Cash, Cash Equivalents, and Marketable Securities Available-for-Sale Securities Available-for-sale securities as of September 30, 2024 were as follows:
|  | September 30, 2024 |
(in thousands) |  | Amortized Cost |  |  | Gross Unrealized Gains |  |  | Gross Unrealized Losses |  |  | Fair Value |
Cash equivalents (contractual maturity within 90 days): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds |  | $ | 3,897 |  |  | $ | — |  |  | $ | — |  |  | $ | 3,897 |
Total cash equivalents |  |  | 3,897 |  |  |  | — |  |  |  | — |  |  |  | 3,897 |
Cash |  |  | 10,748 |  |  |  | — |  |  |  | — |  |  |  | 10,748 |
Total cash and cash equivalents |  | $ | 14,645 |  |  | $ | — |  |  | $ | — |  |  | $ | 14,645 |
Available-for-sale securities as of December 31, 2023 were as follows:
|  | December 31, 2023 |
(in thousands) |  | Amortized Cost |  |  | Gross Unrealized Gains |  |  | Gross Unrealized Losses |  |  | Fair Value |
Cash equivalents (contractual maturity within 90 days): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury securities |  | $ | 19,883 |  |  | $ | 1 |  |  | $ | — |  |  | $ | 19,884 |
Money market funds |  |  | 5,113 |  |  |  | — |  |  |  | — |  |  |  | 5,113 |
Total cash equivalents |  |  | 24,996 |  |  |  | 1 |  |  |  | — |  |  |  | 24,997 |
Cash |  |  | 3,824 |  |  |  | — |  |  |  | — |  |  |  | 3,824 |
Total cash and cash equivalents |  | $ | 28,820 |  |  | $ | 1 |  |  | $ | — |  |  | $ | 28,821 |
Marketable securities (contractual maturity greater than 90 days but less than 1 year): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury securities |  | $ | 6,179 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,179 |
Total marketable securities |  | $ | 6,179 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,179 |
We had no realized gains or losses from the sale of available-for-sale securities during the three and nine months ended September 30, 2024 and 2023. As of September 30, 2024 and December 31, 2023, we did not have any allowance for credit losses or impairments of available-for-sale securities.

X
- Definition The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent + Details
Name: | us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration